February-March 2012: A Mexican national, age 58, with advanced prostate cancer that had spread to his liver and bones (femur and others) was treated using the core SCRI approach. He had had no prior conventional cancer care such as chemotherapy or radiotherapy. At the time of his initial infusion of donor granulocytes, his PSA level was almost 1000...
538 Hits
538 Hits